FDA Adverse Event Other Summary report: N

IMMULITE 2500

MDR report key: 1933426 · Received December 15, 2010

Report

Report Number
2247117-2010-00057
Event Type
Other
Date Received
December 15, 2010
Date of Event
November 16, 2010
Report Date
November 16, 2010
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC.
Product Code
JJQ
PMA / PMN Number
K905215
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

A SIEMENS HEALTHCARE FIELD SERVICE ENGINEER (FSE) EVALUATED THE INSTRUMENT AND INSTRUMENT DATA. ANALYSIS OF THE INSTRUMENT INDICATE THAT THE CAUSE FOR THE DISCORDANT TROPONIN RESULT IS UNK. THE INSTRUMENT IS PERFORMING WITHIN SPECIFICATIONS. NO FURTHER EVAL OF THE DEVICE IS REQUIRED.

Description of Event or Problem · 1

DISCORDANT HIGH IMMULITE 2500 TROPONIN RESULTS WERE OBTAINED WITH TWO (2) PT SAMPLES. THE LAB REPEATED THE SAMPLES ON A SECOND SYSTEM, WHICH GAVE SIMILAR RESULTS. THE SAMPLES WERE THEN TREATED WITH HBT TUBES AND THE RESULTS FOR BOTH PT'S WERE NEGATIVE. THERE WAS NO KNOWN REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT TROPONIN RESULTS.

Additional Manufacturer Narrative · 2

A SIEMENS HEALTHCARE FIELD SERVICE ENGINEER (FSE) EVALUATED THE INSTRUMENT AND INSTRUMENT DATA. ANALYSIS OF THE INSTRUMENT INDICATE THAT THE CAUSE FOR THE DISCORDANT TROPONIN RESULT IS UNK. THE INSTRUMENT IS PERFORMING WITHIN SPECIFICATIONS. NO FURTHER EVAL OF THE DEVICE IS REQUIRED.

Description of Event or Problem · 2

DISCORDANT HIGH IMMULITE 2500 TROPONIN RESULTS WERE OBTAINED WITH TWO (2) PT SAMPLES. THE LAB REPEATED THE SAMPLES ON A SECOND SYSTEM, WHICH GAVE SIMILAR RESULTS. THE SAMPLES WERE THEN TREATED WITH HBT TUBES AND THE RESULTS FOR BOTH PT'S WERE NEGATIVE. THERE WAS NO KNOWN REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT TROPONIN RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 IMMULITE 2500 IMMUNO-ASSAY JJQ SIEMENS HEALTHCARE DIAGNOSTICS INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1
2